These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38811808)
1. Hexanucleotide repeat expansion in SCA36 reduces the expression of genes involved in ribosome biosynthesis and protein translation. Morikawa T; Miura S; Uchiyama Y; Hiruki S; Sun Y; Fujioka R; Shibata H J Hum Genet; 2024 Sep; 69(9):411-416. PubMed ID: 38811808 [TBL] [Abstract][Full Text] [Related]
2. Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion. Obayashi M; Stevanin G; Synofzik M; Monin ML; Duyckaerts C; Sato N; Streichenberger N; Vighetto A; Desestret V; Tesson C; Wichmann HE; Illig T; Huttenlocher J; Kita Y; Izumi Y; Mizusawa H; Schöls L; Klopstock T; Brice A; Ishikawa K; Dürr A J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):986-95. PubMed ID: 25476002 [TBL] [Abstract][Full Text] [Related]
3. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Kobayashi H; Abe K; Matsuura T; Ikeda Y; Hitomi T; Akechi Y; Habu T; Liu W; Okuda H; Koizumi A Am J Hum Genet; 2011 Jul; 89(1):121-30. PubMed ID: 21683323 [TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical analysis of spinocerebellar ataxia type 36 in Mainland China. Zeng S; Zeng J; He M; Zeng X; Zhou Y; Liu Z; Xia K; Pan Q; Jiang H; Shen L; Yan X; Tang B; Wang J Clin Genet; 2016 Aug; 90(2):141-8. PubMed ID: 26661328 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of SCA36: a novel spinocerebellar ataxia with motor neuron involvement (Asidan). Ikeda Y; Ohta Y; Kobayashi H; Okamoto M; Takamatsu K; Ota T; Manabe Y; Okamoto K; Koizumi A; Abe K Neurology; 2012 Jul; 79(4):333-41. PubMed ID: 22744658 [TBL] [Abstract][Full Text] [Related]
6. Long-read sequencing identified intronic (GGCCTG)n expansion in NOP56 in one SCA36 family and literature review. Wang Q; Zhang C; Liu S; Liu T; Ni R; Liu X; Zhong P; Wu Q; Xu T; Ke H; Tian W; Cao L Clin Neurol Neurosurg; 2022 Dec; 223():107503. PubMed ID: 36368168 [TBL] [Abstract][Full Text] [Related]
7. Suppression of the yeast elongation factor Spt4 ortholog reduces expanded SCA36 GGCCUG repeat aggregation and cytotoxicity. Furuta N; Tsukagoshi S; Hirayanagi K; Ikeda Y Brain Res; 2019 May; 1711():29-40. PubMed ID: 30610877 [TBL] [Abstract][Full Text] [Related]
8. [Recent advances in clinical and genetic research of spinocerebellar ataxia type 36]. Zeng S; Tang B; Wang J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):886-9. PubMed ID: 26663071 [TBL] [Abstract][Full Text] [Related]
12. Frequency of SCA8, SCA10, SCA12, SCA36, FXTAS and C9orf72 repeat expansions in SCA patients negative for the most common SCA subtypes. Aydin G; Dekomien G; Hoffjan S; Gerding WM; Epplen JT; Arning L BMC Neurol; 2018 Jan; 18(1):3. PubMed ID: 29316893 [TBL] [Abstract][Full Text] [Related]
13. A Chinese SCA36 pedigree analysis of Zou J; Wang F; Gong Z; Wang R; Chen S; Zhang H; Sun R; Gao C; Li W; Shang J; Zhang J Front Genet; 2023; 14():1110307. PubMed ID: 37051597 [No Abstract] [Full Text] [Related]
14. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151 [TBL] [Abstract][Full Text] [Related]
15. Screening for spinocerebellar ataxia type 36 (SCA36) in the Greek population. Katsimpouris D; Kartanou C; Breza M; Panas M; Koutsis G; Karadima G J Neurol Sci; 2019 Jul; 402():131-132. PubMed ID: 31132534 [No Abstract] [Full Text] [Related]
16. The roles of NOP56 in cancer and SCA36. Zhao S; Zhang D; Liu S; Huang J Pathol Oncol Res; 2023; 29():1610884. PubMed ID: 36741964 [TBL] [Abstract][Full Text] [Related]